Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic diseases worldwide. As a multifaceted disease, NAFLD’s pathogenesis is not entirely understood, but recent evidence reveals that gut microbiota plays a significant role in its progression. Butyrate, a gut microbiota metaboli...

Full description

Bibliographic Details
Main Authors: Parichehr Amiri, Sara Arefhosseini, Farnush Bakhshimoghaddam, Hannah Jamshidi Gurvan, Seyed Ahmad Hosseini
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2022.1037696/full
_version_ 1811316483689545728
author Parichehr Amiri
Parichehr Amiri
Parichehr Amiri
Sara Arefhosseini
Farnush Bakhshimoghaddam
Farnush Bakhshimoghaddam
Farnush Bakhshimoghaddam
Hannah Jamshidi Gurvan
Seyed Ahmad Hosseini
Seyed Ahmad Hosseini
author_facet Parichehr Amiri
Parichehr Amiri
Parichehr Amiri
Sara Arefhosseini
Farnush Bakhshimoghaddam
Farnush Bakhshimoghaddam
Farnush Bakhshimoghaddam
Hannah Jamshidi Gurvan
Seyed Ahmad Hosseini
Seyed Ahmad Hosseini
author_sort Parichehr Amiri
collection DOAJ
description Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic diseases worldwide. As a multifaceted disease, NAFLD’s pathogenesis is not entirely understood, but recent evidence reveals that gut microbiota plays a significant role in its progression. Butyrate, a gut microbiota metabolite, has been reported to have hepato-protective effects in NAFLD animal models. The purpose of this systematic review is to determine how butyrate affects the risk factors for NAFLD. Searches were conducted using relevant keywords in electronic databases up to March 2022. According to the evidence presented in this study, butyrate contributes to a wide variety of biological processes in the gut–liver axis. Its beneficial properties include improving intestinal homeostasis and liver health as well as anti-inflammatory, metabolism regulatory and anti-oxidative effects. These effects may be attributed to butyrate’s ability to regulate gene expression as an epigenetic modulator and trigger cellular responses as a signalling molecule. However, the exact underlying mechanisms remain unclear. Human trials have not been performed on the effect of butyrate on NAFLD, so there are concerns about whether the results of animal studies can be translated to humans. This review summarises the current knowledge about the properties of butyrate, particularly its potential effects and mechanisms on liver health and NAFLD management.
first_indexed 2024-04-13T11:50:43Z
format Article
id doaj.art-852ca05bf68f46878447ba7993c2c721
institution Directory Open Access Journal
issn 2296-861X
language English
last_indexed 2024-04-13T11:50:43Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj.art-852ca05bf68f46878447ba7993c2c7212022-12-22T02:48:04ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2022-12-01910.3389/fnut.2022.10376961037696Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic reviewParichehr Amiri0Parichehr Amiri1Parichehr Amiri2Sara Arefhosseini3Farnush Bakhshimoghaddam4Farnush Bakhshimoghaddam5Farnush Bakhshimoghaddam6Hannah Jamshidi Gurvan7Seyed Ahmad Hosseini8Seyed Ahmad Hosseini9Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranNutrition and Metabolic Diseases Research Center, Clinical Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranDepartment of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranStudent Research Committee, Tabriz University of Medical Sciences, Tabriz, IranStudent Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranNutrition and Metabolic Diseases Research Center, Clinical Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranDepartment of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranNational Medical Emergency Organization, Ministry of Health and Medical Education, Tehran, IranNutrition and Metabolic Diseases Research Center, Clinical Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranDepartment of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranNon-alcoholic fatty liver disease (NAFLD) is one of the most common chronic diseases worldwide. As a multifaceted disease, NAFLD’s pathogenesis is not entirely understood, but recent evidence reveals that gut microbiota plays a significant role in its progression. Butyrate, a gut microbiota metabolite, has been reported to have hepato-protective effects in NAFLD animal models. The purpose of this systematic review is to determine how butyrate affects the risk factors for NAFLD. Searches were conducted using relevant keywords in electronic databases up to March 2022. According to the evidence presented in this study, butyrate contributes to a wide variety of biological processes in the gut–liver axis. Its beneficial properties include improving intestinal homeostasis and liver health as well as anti-inflammatory, metabolism regulatory and anti-oxidative effects. These effects may be attributed to butyrate’s ability to regulate gene expression as an epigenetic modulator and trigger cellular responses as a signalling molecule. However, the exact underlying mechanisms remain unclear. Human trials have not been performed on the effect of butyrate on NAFLD, so there are concerns about whether the results of animal studies can be translated to humans. This review summarises the current knowledge about the properties of butyrate, particularly its potential effects and mechanisms on liver health and NAFLD management.https://www.frontiersin.org/articles/10.3389/fnut.2022.1037696/fullNAFLDbutyrateobesitygut microbiotainsulin resistance
spellingShingle Parichehr Amiri
Parichehr Amiri
Parichehr Amiri
Sara Arefhosseini
Farnush Bakhshimoghaddam
Farnush Bakhshimoghaddam
Farnush Bakhshimoghaddam
Hannah Jamshidi Gurvan
Seyed Ahmad Hosseini
Seyed Ahmad Hosseini
Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review
Frontiers in Nutrition
NAFLD
butyrate
obesity
gut microbiota
insulin resistance
title Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review
title_full Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review
title_fullStr Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review
title_full_unstemmed Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review
title_short Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review
title_sort mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on nafld management a systematic review
topic NAFLD
butyrate
obesity
gut microbiota
insulin resistance
url https://www.frontiersin.org/articles/10.3389/fnut.2022.1037696/full
work_keys_str_mv AT parichehramiri mechanisticinsightsintothepleiotropiceffectsofbutyrateasapotentialtherapeuticagentonnafldmanagementasystematicreview
AT parichehramiri mechanisticinsightsintothepleiotropiceffectsofbutyrateasapotentialtherapeuticagentonnafldmanagementasystematicreview
AT parichehramiri mechanisticinsightsintothepleiotropiceffectsofbutyrateasapotentialtherapeuticagentonnafldmanagementasystematicreview
AT saraarefhosseini mechanisticinsightsintothepleiotropiceffectsofbutyrateasapotentialtherapeuticagentonnafldmanagementasystematicreview
AT farnushbakhshimoghaddam mechanisticinsightsintothepleiotropiceffectsofbutyrateasapotentialtherapeuticagentonnafldmanagementasystematicreview
AT farnushbakhshimoghaddam mechanisticinsightsintothepleiotropiceffectsofbutyrateasapotentialtherapeuticagentonnafldmanagementasystematicreview
AT farnushbakhshimoghaddam mechanisticinsightsintothepleiotropiceffectsofbutyrateasapotentialtherapeuticagentonnafldmanagementasystematicreview
AT hannahjamshidigurvan mechanisticinsightsintothepleiotropiceffectsofbutyrateasapotentialtherapeuticagentonnafldmanagementasystematicreview
AT seyedahmadhosseini mechanisticinsightsintothepleiotropiceffectsofbutyrateasapotentialtherapeuticagentonnafldmanagementasystematicreview
AT seyedahmadhosseini mechanisticinsightsintothepleiotropiceffectsofbutyrateasapotentialtherapeuticagentonnafldmanagementasystematicreview